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This paper describes some physical, structural, and biological properties of gypsum bioceramics doped with various amounts of
strontium ions (0.19–2.23wt%) and compares these properties with those of a pure gypsum as control. Strontium-doped gypsum
(gypsum:Sr) was obtained by mixing calcium sulfate hemihydrate powder and solutions of strontium nitrate followed by washing
the specimens with distilled water to remove residual salts. Gypsum was the only phase found in the composition of both pure
and gypsum:Sr, meanwhile a shift into lower diﬀraction angles was observed in the X-ray diﬀraction patterns of doped specimens.
Microstructure of all gypsum specimens consisted of many rod-like small crystals entangled to each other with more elongation
and higher thickness in the case of gypsum:Sr. The Sr-doped sample exhibited higher compressive strength and lower solubility
than pure gypsum. A continuous release of strontium ions was observed from the gypsum:Sr during soaking it in simulated body
ﬂuidfor14days.Comparedtopuregypsum,theosteoblastsculturedonstrontium-dopedsamplesshowedbetterproliferationrate
and higher alkaline phosphatase activity, depending on Sr concentration. These observations can predict better in vivo behavior
of strontium-doped gypsum compared to pure one.
1.Introduction
Because strontium is chemically and physically similar to
calcium,itisatraceelementthataccumulatesintheskeleton,
preferably in new trabecular bone, depending on the skeletal
site. Sr content increases in the sequence diaphysis of the
femur, lumbar vertebra, and iliac crest [1].
Strontium (Sr) salts were found to stimulate bone for-
mation and inhibit bone resorption both in vitro and in vivo
[2]. The oral strontium-containing drugs have recently been
recommended as drug associated with treating osteoporosis
[3]. The stimulatory eﬀects of strontium on bone collagen
synthesis has been reported in vitro, while neither calcium
nor sodium salts were eﬀective [4].
In the past decade, a wide range of bioceramics such
as hydroxyapatite, tricalcium phosphate, octacalcium
phosphate, and bioactive glasses have been studied for
orthopaedic applications [5–7]. Because of the beneﬁcial
eﬀects of strontium on the treatment of bone diseases and
defects, many studies have focused on synthesis, charac-
terization, and animal modeling of strontium-containing
bioceramics. Many authors attempted to incorporate Sr
into crystal lattice of calcium phosphates either through a
high temperature synthesis [8] or by precipitation during
a setting reaction of hydroxyapatite forming cement [9].
Strontium-containing hydroxyapatite was mixed with bone
cement [10, 11] to promote osteoblast attachment and
mineralization in vitro [12] and accelerate bone growth
and osteointegration in vivo [13]. Strontium-substituted
beta-tricalcium phosphate was synthesized and used as a
reactant of calcium phosphate cement with a Sr2+ release
range of 12–30ppm. Sr-doped hydroxyapatite was used as
plasma-sprayed coating layer where a simulated cell response
was observed for this layer compared to pure hydroxyapatite2 Bioinorganic Chemistry and Applications
Table 1: Details of various paste formulations for preparation of Sr-doped gypsum along with their names.
Name of specimen
G-0 G-Sr1 G-Sr2 G-Sr3 G-Sr4
Assumed Sr content in gypsum (%) 0 0.25 0.5 1.25 2.5
Concentration of Sr(NO3) solution used
as liquid phase in paste (%) 0 1.36 2.80 7.04 14.08
Solid phase of paste α-CHS α-CHS α-CHS α-CHS α-CHS
[14]. Incorporation of strontium into bioactive glasses has
been also reported by some authors. Abou Neel et al. [15]
reported structural and physical properties of melt-derived
phosphate-based glasses in which positive eﬀect of Sr-doped
glasses on viability of human osteoblastic cells was reported.
Physicochemical and in vitro cellular properties of sol-gel-
derived bioactive glasses based on CaO-SrO-SiO2-P2O5
system were reported by Hesaraki et al. [16].
Calcium sulfates are biocompatible and biodegradable
materials used for the treatment of bone and periodontal
defects for many years. Calcium sulfate can be used as a
bulk material, space ﬁller, and vehicle for a controlled release
of certain drugs, associated with other graft materials [17–
19]. A number of positive clinical experiences are available
with calcium sulfate in bone substitution procedures [20].
Gypsum is dihydrate form of calcium sulfate (CaSO4-
2H2O) synthetically made from Plaster of Paris, hemihydrate
form of calcium sulfate (CaSO4-1/2H2O). Gypsum with a
microstructure comprising a lot of small crystals entangled
to each other, suggested that provides a more eﬃcient
environment for bone repair. It has been stated that gypsum
not only is passive osteoconductive material but also might
has a potential to be osteoinductive due to its special crystal
structure, and high calcium content [21].
Theaimofthisstudywastoincorporatevariouscontents
of strontium ions into calcium sulfate dihydrate (gypsum)
crystal lattice and to investigate the eﬀect of this substitution
on some physicochemical, structural and in vitro cellular
properties of the material.
2.MaterialsandMethods
2.1. Starting Materials and Trade Marks. The following
starting materials were used in this study: alpha-calcium
sulfate hemihydrate (α-CSH, Aldrich, USA), strontium
nitrate (Merck, Germany), sodium chloride (Merck, Ger-
many), potassium chloride (Merck, Germany), calcium
chloride dihydrate (Merck, Germany), sodium hydrogen
carbonate (Merck, Germany), dipotasium hydrogen phos-
phate trihydrate (Merck, Germany), sodium sulfate dec-
ahydrate (Merck, Germany), magnesium chloride hexa-
hydrate (Merck, Germany), tris-hydroxymethyl amino-
methane (Merck, Germany), and hydrochloric acid (Merck,
Germany). Except α-CSH and strontium nitrate, all the
above mentioned precursors were used for the preparation
of simulated body ﬂuid (SBF) solution.
2.2. Preparation of Strontium-Doped Gypsum Specimens.
Strontium-doped gypsum bioceramics (gypsum:Sr) were
prepared from the setting process of calcium sulfate hemihy-
drate. Calcium sulfate hemihydrate was mixed with aqueous
solution of strontium nitrate at a solid to liquid loading
of 2g/mL and the obtained paste was poured into a disc-
shaped Teﬂon mold (10mm in diameter and 3mm in
height) and left to set. Various concentrations of strontium
nitrate were used to achieve gypsum product with diﬀerent
concentrations of strontium doped ions. Pure distilled water
was also used to fabricate gypsum product without any
additive as control sample (G-0). Table 1 presents details of
various paste formulations of Sr-doped gypsum specimens
along with the code of each formulation. When the pastes
were completely hardened (set), the specimens were taken
from the mold, incubated in 100% humidiﬁed atmosphere
at 37◦C for 24h, washed with distilled water for several times
to remove the residuals and soluble salts, and,ﬁnally, dried at
room temperature for 72h.
2.3. Experimental Procedures
2.3.1.ConcentrationofStrontiuminGypsum:Sr. Theconcen-
tration of strontium ions in the Sr-doped gypsum specimens
was measured using inductively coupled plasma-atomic
emission spectroscopy (ICP-AES) technique ARL 3410.
2.3.2. Phase Composition. Phase compositions of the speci-
mens were determined using an X-ray diﬀractometer device
(XRD, Philips PW 3710) with Cu-Kα radiation, an operating
voltage of 40kV, and a scanning rate of 0.02 2θ/s . For this
purpose, the same weight of each specimen in powdered
f o r mw a sd e l i v e r e dt oX R Du n i t .T h eX R Dp a t t e r n sw e r e
assessed by X’Pert HighScore software, version 1.0d, 2003
(PANalytical B.V., Almelo, The Netherlands).
2.3.3. Chemical Groups. To investigate the structural
characteristics of the specimens, Fourier-transform infrared
(FTIR) spectroscopy was used with KBr powder as a
standard. Transparent discs were prepared by mixing the
sample and the standard KBr at the KBr/sample ratio of 10
(in w/w). The FTIR spectra of the specimens were collected
at 4000–400cm−1 region with 2cm−1 resolution using
Bruker Vector 33.
2.3.4. Microstructural Observations and Elemental Image
Analysis. The microstructure of the pure gypsum and gyp-
sum:Sr specimens were observed using an scanning electron
microscope (TESCAN, VEGA II, XMU) operated at an
accelerating voltage of 40kV and equipped with energy
dispersive X-ray analyzing (EDXA) device.Bioinorganic Chemistry and Applications 3
2.3.5. Density. The powder density of the specimens was
measured using a gas pycnometer device (Accupyc 1330,
Micromeritics). For this purpose the dried hardened samples
were powdered, passed through a 230 mesh sieve, and then
characterized.
2.3.6. Compressive Strength. To understand the eﬀect of
incorporation of Sr2+ ions into gypsum on its mechan-
ical strength, gypsum:Sr cylindrical specimens (6mm in
diameter and 12mm in height) were fabricated in Teﬂon
mold as described in Section 2.2.E a c hs a m p l ew a sk e p t
in a SBF solution for 24h and the compressive strength
of wet specimens was recorded using a universal testing
device (Zwick/Roell-HCR 25/400) at a crosshead speed
of 1mm/min. In this study, the SBF solution with a
chemical composition resembling that of human blood
plasma (solution with ionic concentration of Na+ 142.0, K+
5.5, Mg2+ 1.5, Ca2+ 2.5, Cl− 147.8, HCO3
− 4.2, HPO4
2−
1.0 and SO4
2− 0.5mM) was prepared by dissolving the
chemical reagents in distilled water, buﬀering it with tris-
hydroxymethyl aminomethane and adjusting its pH to 7.4
using hydrochloric acid [22].
2.3.7. Solubility. The solubility of gypsum and gypsum:Sr
specimens were investigated through immersing disc-shaped
specimens in the SBF solution at solid to solution loading
of 1.6g/100mL and measuring the concentration of Ca and
Sr ions released from the specimens into the solution (using
ICP-AES instrument) as a function of time. Note that after
eachevaluatingperiod,thewholevolumeoftheSBFsolution
was extracted for analysis and the sample was immediately
fed with a fresh solution. Cumulative concentration of each
ion was calculated using the following expression:
[Sr]n =
i=n 
i=1
[Sr]i,( 1 )
where [Sr]n is cumulative concentration of Sr ions at the nth
period of evaluation and i is the evaluating time interval.
2.3.8. Cell Proliferation and Alkaline Phosphatase Activity. To
study the eﬀect of incorporation of strontium into gypsum
biomaterial on the viability and alkaline phosphatase activity
of the osteoblastic cells, the in vitro tests were carried
out using the human osteosarcoma (G-292) cells (NCBI C
116 National Cell Bank of Iran). The cells were cultured
in tissue culture polystyrene (PS) ﬂasks (Falcon, USA) at
37◦C under 5% CO2 atmosphere in Dulbecco’s modiﬁed
Eagle’s medium (DMEM) with l-glutamine, supplemented
10% fetal bovine serum (FBS) and antibiotic antimycotic
(100 units penicillin G sodium, 100mg streptomycin sulfate,
and 0.25mg amphotericin B in saline) and harvested after
the treatment with 0.05% trypsin-EDTA.
The proliferation of osteoblast cells onto the gypsum
specimens was measured by MTT assay. The samples were
sterilized with 70% ethanol and seeded with the cells at 3 ×
104 cells/disc. Polystyrene discs with the surface area similar
to gypsum specimens were prepared from the tissue culture
plateandsimilarlywereseededwiththecellsascontrolspeci-
mens.Thespecimen/cellconstructswereplacedinto24-wells
culture plates and left undisturbed in an incubator for 4h
to allow the cells to attach to them. Then, 3mL of culture
medium was added into each well and the cell/specimen
constructs were cultured in a humidiﬁed incubator at 37◦C
with 95% air and 5% CO2 for 1, 3, and 7 days. The medium
was changed every 3 days. After each period, the medium
was removed and 2mL of MTT, 3-(4,5 dimethylthiazol-2-
yl)-2,5-diphenyl tetrazolium bromide, solution was added
to each well. Following incubation at 37◦Cf o r4 hi na
fully humidiﬁed atmosphere of 5% CO2/95% air, MTT was
taken up by active cells and reduced in the mitochondria
to insoluble purple formazan granules. Subsequently, the
medium was discarded and the precipitated formazan was
dissolved in dimethylsulfoxide, DMSO, (150mL/well), and
optical density of the solution was read using a microplate
spectrophotometer (BIO-TEK Elx 800, Highland park, USA)
at a wavelength of 570nm. The optical density (OD) was
measured at the wavelength of 590nm using a multiwell
microplate reader (ICN, Switzerland).
The osteoblast activity was determined by measuring
the level of alkaline phosphatase (ALP) produced by G-292
cells. The cells were seeded on the samples under the same
culturing condition described above and the level of ALP
activity were determined on days 1, 3, and 7. The G-292
cell lysates were frozen and thawed three times to disrupt
the cell membranes. ALP activity was determined at 405nm
using p-nitrophenyl phosphate in diethanolamide buﬀer as
chromogenic substrate.
2.3.9. Statistical Analysis. Data were processed using
Microsoft Excel 2003 software and the results were produced
as mean ± standard deviation of at least 4 experiments.
Signiﬁcance between the mean values was calculated
using standard software program (SPSS GmbH, Munich,
Germany) and the P ≤ 0.05 was considered signiﬁcant.
3. Results and Discussion
3.1. Concentration of Strontium in Sr-Doped Gypsum. In this
study Sr-doped gypsum was prepared through conversion
of calcium sulfate hemihydrate phase into calcium sulfate
dihydrate through a hydraulic reaction at the presence of
Sr solution. The mechanisms of gypsum formation have
been discussed elsewhere [23]. The samples were kept in
a 100% humid atmosphere until all starting hemihydrate
phase is converted to dihydrate form (gypsum). The samples
were washed with distilled water to avoid the presence of
residual soluble strontium or calcium nitrates in the formed
porous matrix. Table 2 presents the concentration of Ca
and Sr elements in gypsum and gypsum:Sr measured by
ICP technique. The Sr content increased with increasing the
amount of added Sr salt. The molar concentration of Sr in
the gypsum:Sr specimens is in the range of 0.4–5.2mol%
of Ca. The normal concentration of Sr in human skeleton
is ∼3.5mol % of Ca [24]. The results can describe why the4 Bioinorganic Chemistry and Applications
Table 2: The weight percentage of Ca and Sr elements in various
Sr-doped gypsum specimens (measured by ICP-AES technique).
G-0 G-Sr1 G-Sr2 G-Sr3 G-Sr4
Ca (%) 22.11 21.79 21.65 20.18 19.79
Sr (%) <10 p.p.m 0.19 0.38 1.11 2.23
strontium was not added in more concentrations than the
selected values.
3.2. Phase Composition. Figure 1 shows the XRD patterns
of the calcium sulfate specimens with various contents of
Sr dopant after hardening and washing with distilled water.
All specimens show sharp and narrow peaks of gypsum
and no other phases are found in the patterns. The X-ray
diﬀraction patterns of gypsum:Sr specimens reveal a shift to
lower diﬀraction angles when Sr concentration is increased,
indicating that Sr ions are incorporated into lattice structure
of gypsum crystals. In comparison with pure gypsum, the
X-ray diﬀraction patterns of Sr-doped gypsum specimens
also show an increase in the intensity of the peaks at 2θ =
11.8◦ corresponding to 020 crystal planes which is indicative
of a preferred direction of gypsum crystal growth during
hydration process.
3.3. Chemical Groups. The FTIR spectra of pure gypsum and
Sr-doped gypsum (G-Sr4) are shown in Figure 2. The spec-
trum of as-set G-Sr4 specimen (hardened specimen before
washing with distilled water) and its spectrum once after
washing with distilled water are also shown for comparison.
The FTIR spectra show the stretching bands associated to
the functional groups of the gypsum components, that is,
H2OandSO 4
2− groupslabeledinthecorrespondingFigures.
The FTIR spectra of all other Sr-doped gypsum specimens
were closely similar to that of G-Sr4 and thus have not been
illustrated. Decreased intensity of nitrate band once after
washing and disappearance of this band after completion
of the washing procedure conﬁrms removal of the residual
additive. As it is observed, the spectrum of gypsum:Sr is
similar to the spectrum of pure gypsum and no extra bands
are found.
3.4. Microstructural Observations and Elemental Image Anal-
ysis. The SEM images of the specimens along with their
corresponding EDXA patterns are illustrated in Figures 3 to
6. Microstructure of pure gypsum (Figure 3(a))w a sf o u n d
to consists of many rod-like crystals entangled to each other
and its corresponding EDXA pattern (Figure 3(b)) shows
the presence of calcium and sulfur as main elements of
gypsum as well as gold (Au) element created from the
coating layer. Micrographs of Sr-doped gypsum specimens
(Figure 4: G-Sr1, Figure 5: G-Sr2 and Figure 6: G-Sr4) show
thicker rod-like crystals with more elongated and compacted
morphologies compared to pure gypsum. In these images,
the EDXA patterns taken from that crystal marked with an
arrow reveal the presence of strontium dopant element in
thecompositionofgypsum.Regardinguniformmorphology
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Figure 1: The XRD patterns of gypsum specimens with content of
doped Sr.
400 600 800 1000 1200 1400 1600 1800 2000
T
r
a
n
s
m
i
t
t
a
n
c
e
H2O
H2O
NO−
3 SO2−
4
SO2−
4 SO2−
4
(G-0)
(G-Sr4)
(as-set
G-Sr4)
(as-set G-Sr4
once after 
washing)
Wavenumber (cm−1)
Figure 2: The FTIR spectra of pure gypsum (G-0) and Sr-doped
gypsum (G-Sr4) in comparison with as-set G-Sr4 and G-Sr-4
specimen once after washing procedure.
of the crystals and lack of other phases in the gypsum:Sr
(from XRD data), these EDXA patterns can be used as
complementary proofs for incorporation of Sr ions into
lattice structure of gypsum.
3.5. Density. Figure 7 shows the eﬀect of incorporation of
Sr2+ ions into gypsum on its powder density. An increase
in density of gypsum powder is observed by adding Sr
in which the increase correlates with Sr concentration and
the diﬀerences are statistically signiﬁcant (P<0.05). The
increased powder density of Sr-doped gypsum in compari-
son with pure gypsum is due to the higher atomic weight of
Sr (87.6g/mol) compared to Ca (40.0g/mol).
3.6. Compressive Strength. Figure 8 shows the compressive
strength of the gypsum bioceramics doped with variousBioinorganic Chemistry and Applications 5
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Figure 3: The SEM image of pure gypsum (a) along with its corresponding EDXA patterns (b).
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Figure 4: The SEM image of G-Sr1 specimen (a) along with its corresponding EDXA patterns (b).
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Figure 5: The SEM image of G-Sr2 specimen (a) along with its corresponding EDXA patterns (b).6 Bioinorganic Chemistry and Applications
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Figure 6: The SEM image of G-Sr4 specimen (a) along with its corresponding EDXA patterns (b).
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Figure 7: The powder density of gypsum specimens containing
diﬀe r e n tc o n t e n t so fS rd o p a n t .
contents of strontium. There is no signiﬁcant diﬀerence
between the compressive strength values of the gypsum
containing various amounts of Sr (P>0.05). However the
compressive strength value of pure gypsum is signiﬁcantly
lower than that of Sr-doped ones. Generally, mechanical
strength of ceramic bodies is ruled by their microstructural
features. In the case of calcium sulfate, entanglement of
rod-like crystals is responsible for mechanical hardening
phenomenon. These crystals are gypsum produced from
conversionofcalciumsulfatehemi-hydratetocalciumsulfate
dihydrate through a dissolution-precipitation process [25].
The size (length and thickness) of these entangled crystals
and their compression in the microstructure can aﬀect
the mechanical properties of gypsum. Note that thick and
protracted crystals of gypsum:Sr tightly locked to each other
(Figures 4 to 6) were to ﬁnd why the compressive strength of
pure gypsum is lower than that of gypsum:Sr.
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Figure 8: Compressive strength of gypsum specimens containing
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3.7. Solubility and Strontium Release. The ion release of gyp-
sum ceramics in the SBF solution is shown in Figure 9. This
experiment was carried out with periodic exchange of SBF
solution and the results are presented as cumulative concen-
tration of Ca (Figure 9(a))a n dS r( Figure 9(b)) against the
immersion time. According to Figure 9(a), the concentration
of Ca ions released from all gypsum specimens is much
higher than that of other calcium phosphates reported in
other studies [26]. It originates from the higher solubility
and thus higher bioresorption rate of calcium sulfate-based
materials in comparison with other well-known bioceramics
such as β-tricalcium phosphate and hydroxyapatite. The
concentration of Ca2+ ions released from pure gypsum (G-
0) into the SBF solution was slightly higher than that of
gypsum:Sr specimens. Since the calcium concentration is
proportional to resorption rate of such bioceramics, the
results demonstrate that incorporation of strontium ionsBioinorganic Chemistry and Applications 7
0
200
400
600
800
1000
1200
1400
1600
1800
2000
02468 1 0 1 2 14
C
u
m
u
l
a
t
i
v
e
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
o
f
 
C
a
 
(
p
.
p
.
m
)
 
Immersion time (day)  
G-0
G-Sr1
G-Sr2
G-Sr3
G-Sr4
(a)
0
20
40
60
80
100
120
02468 1 0 1 2 1 4
C
u
m
u
l
a
t
i
v
e
 
c
o
n
c
e
n
t
r
a
t
i
o
n
 
o
f
 
S
r
 
(
p
.
p
.
m
)
Immersion time (day)
G-Sr1
G-Sr2
G-Sr3
G-Sr4
(b)
Figure 9: Cumulative concentration of Ca (a) and Sr (b) ions released from various Sr-doped specimens into the SBF solution.
into gypsum can diminish the biomaterial resorption rate.
This decreased degradation rate of gypsum:Sr indicates
higher chemical stability of these materials compared to pure
gypsum. It is suggested that this is due to the complicated
movement Ca ions in the crystal when encountering with
Sr ions having larger atomic radius. The higher bonding
strength of Sr-sulfate group in comparison with Ca-sulfate
group should not be ignored too (note that Sr is more
electronegative than Ca [27]). Calcium sulfate-based bioce-
ramics have been used as potential materials for bone tissue
regeneration, because of their adequate biocompatibility and
osteoconductivity. However, the high degradation rate of
these materials is the main practical problem [28], resulting
in material to be lost in defect site before the completion of
tissue repair. Incorporation of strontium into gypsum may
c o n t r o li t st o of a s tr e s o r p t i o nr a t et os o m ee x t e n t .
The results clearly showed a continuous release of
incorporated strontium ions into the SBF medium. It means
that the gypsum can act as a suitable material for releasing
Sr and stimulating osteoblastic cells and tissue repair. The
concentration of Sr2+ ions in the SBF is proportional to
the Sr content in the gypsum. At the end of the evaluation
period (14 day), cumulative Sr release was 18mg/g/L for G-
Sr1 (about 4.7–8.9mmol/g/day) and 114mg/g/L for G-Sr4
(about 20–25mmol/g/day). Regarding the therapeutic dose
of Sr2+ (as strontium ranelate) which is in the range of 2.4–
8.75mmol/day (per kg of rat) for oral administration [4],
the level of Sr2+ ions released from gypsum:Sr of this study
is higher than that of Sr-substituted hydroxyapatite reported
by Landi et al. [29] and comparable to that of Sr-doped beta-
tricalcium phosphate bioceramics reported by Alkhraisat et
al. [26]. The concentration of the released Sr2+ ions should
be in therapeutic range, because osteoclasts are inhibited by
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Figure 10: Proliferation of G-292 osteoblastic cells on gypsum
specimens with various amounts of Sr dopant (∗P<0.05).
the eﬀective dose of these ions. The maximum Sr/Ca molar
ratio in the SBF is about 0.03, which is in the range of Sr/Ca
in bone skeleton [24]. Generally, our results showed that
the release of Sr2+ ions into an SBF and thus into a cell
culture medium can be tailored by varying its concentration
in gypsum crystals.
3.8. Cell Proliferation and Alkaline Phosphatase Activity.
Figure 10 shows the results of G-292 cell proliferation
on the polystyrene (control), pure gypsum, and Sr-doped8 Bioinorganic Chemistry and Applications
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Figure 11: Normalized ALP activity of G-292 osteoblastic cells
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gypsum specimens. After cell attachment, the osteoblasts
proliferate on all specimens because of the diﬀerence in
cell number between days 1, 3 and 7 (P<0.05). In this
study, it was found that the proliferation of the cells on
gypsum specimens was signiﬁcantly (P<0.05) better than
on control specimen, meanwhile the osteoblastic cells could
proliferate on some gypsum:Sr discs at a signiﬁcantly higher
rate than on pure gypsum. Firstly, according to Laz´ ary et
al. [21], physical structure of gypsum may be responsible
for the suitable proliferation of osteoblastic cells onto the
gypsum specimen. In other words, the cells can be attached
onto the gypsum surfaces because it has been formed from
Plaster of Paris (CaSO4-hemihydrate) by adding water and
its microstructure is composed of too many rod-like small
crystals entangled to each other to provide large speciﬁc
surfacearea.Secondly,ithasbeenprovedthatstrontiumions
can stimulate cellular responses and subsequently increase
rate of cell proliferation process. In this study, the eﬀect
of Sr2+ on proliferation of osteoblastic cells was proved to
be dose-dependent, because of the lower proliferation rate
of the osteoblasts on G-Sr4 compared with other Sr-doped
samples. It is in agreement with other studies [30].
Alkaline phosphatase is known as an early osteoblastic
diﬀerentiation marker and is produced by the cells showing
mineralized extracellular matrix [31]. Alkaline phosphatase
activity of the osteoblasts is illustrated in Figure 11 as nor-
malized absorbance number (per unit cell number) against
the culture time. ALP activity of the osteoblasts cultured
on gypsum specimens, especially G-Sr1, was better than
those cultured on polystyrene. While higher ALP activity
was found on G-Sr1 compared to gypsum, the diﬀerence
in ALP value of pure gypsum and other Sr-doped gypsum
specimens was not statistically signiﬁcant (P>0.05).
Alkaline phosphatase activity was inhibited on day 7 for all
specimens probably due to conﬂux of extended cell [16].
There are many studies that conﬁrm this fact that strontium
ions incorporated into composition of bioceramics can
improve proliferation and/or alkaline phosphatase activity of
osteoblastic cells [32]. In this study, it was shown that the
presence of Sr2+ ions in the lattice structure of gypsum could
also play important role in proliferation and ALP activity of
G-292 osteoblastic cells.
4. Conclusions
Calcium sulfate dihydrate (gypsum) bioceramics with
improved compressive strength and cellular properties are
obtained by doping various concentrations of strontium into
crystal lattice of the material. Incorporation of strontium
into gypsum aﬀects its crystal morphology and water
solubility. The Sr-doped gypsum was found to be useful as
strontiumreleasingmaterialwithacontinuousreleaseproﬁle
in which amount of the liberated strontium is dependent
of its concentration in host material. Both proliferation rate
and alkaline phosphatase activity of human osteosarcoma
cells on gypsum:Sr can be improved by incorporation of
strontium,dependingontheSrdoseinthehostlattice.These
observations can also predict better in vivo functions of
strontium-doped gypsum compared to pure gypsum which
requires more investigations.
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